Skip to main content
Clinical Trials/KCT0004441
KCT0004441
Recruiting
未知

ow-intensity Shock Wave Therapy for chronic prostatitis/chronic pelvic pain syndrome(CP/CPPS IIIb); sham controlled, double blind, randomized prospective study

The Catholic University of Korea, Seoul St. Mary's Hospital0 sites30 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
The Catholic University of Korea, Seoul St. Mary's Hospital
Enrollment
30
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional Study
Sex
Male

Investigators

Sponsor
The Catholic University of Korea, Seoul St. Mary's Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\.A male over 20 years old and under 70 years old
  • 2\. Patients who have been diagnosed with chronic pelvic pain syndrome for at least 3 months or who have not been treated or who have been diagnosed and treated for chronic pelvic pain syndrome for more than 3 months
  • 3\. Patients with local pain or discomfort in the perineum or prostate area during physical examination
  • 4\. Patient whose subject or legal representative signed the subject's consent

Exclusion Criteria

  • 1\.Inflammatory bowel disease (Crohn's disease or ulcerative colitis, irritable bowel syndrome)
  • 2\. Patients with acute prostatitis, urinary tract infections with fever within the last 6 months (urethritis, cystitis, etc.)
  • 3\. People suffering from known malignancies over the past two years
  • 4\. Patients who have undergone surgery for urethral stenosis, enlarged prostate, or have undergone prostatectomy, TURP, TUIP, TUMT, TUNA, or prostate biopsy
  • 5\. Prostate surgery within 3 months
  • 6\.PSA\> 4 ng / ml (PSA range 4\-10, biopsy at PI discretion (deferral)
  • 7\. History of nervous system diseases
  • 8\. Blood clotting disorders and anticoagulants
  • 9\. Severe heart disease, heart rate imbalance and hypertension
  • 10\. Heart pacemaker wearers

Outcomes

Primary Outcomes

Not specified

Similar Trials